Current Status of COVID-19 Diagnostics

  • Dixit S
  • Sharma M
N/ACitations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

In December 2019, an unexpected outbreak was caused by novel corona virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The lung disease caused by SARS-CoV-2 was given the name of the novel coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO) on February 11, 2020. Since its origin in the Hubei province of Wuhan city in China, now it has spread to 218 countries worldwide. Panic situation created by COVID-19 has compelled researchers and doctors to work collaboratively. To combat with the disease, every control measures are under consideration from drug discovery to vaccine development. In the management of disease, rapid diagnosis is equally important as development of vaccine and drug. At present, various diagnostic kits are available for COVID-19. With the disease progression, global demand for diagnostics is raising. So, this chapter will include the updates on efficient diagnostic assays and future of diagnostic.

Cite

CITATION STYLE

APA

Dixit, S., & Sharma, M. (2022). Current Status of COVID-19 Diagnostics. In Biotechnology to Combat COVID-19. IntechOpen. https://doi.org/10.5772/intechopen.96955

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free